Designing a Pre-IPO Employee Share Scheme That Survives Regulatory Scrutiny

The Hong Kong Stock Exchange’s (HKEX) enhanced Listing Rules, effective 1 January 2025, introduced a material tightening of the disclosure requirements for pre-IPO share schemes, directly impacting the structuring timeline for any company targeting a Main Board or GEM listing. Specifically, the new Chapter 17 of the Main Board Listing Rules now mandates that any share scheme established within the 12 months prior to the submission of a listing application (Form A1) must be fully disclosed in the prospectus, with the sponsor required to confirm that the scheme’s terms do not circumvent the lock-up and vesting provisions designed to align management interests with public shareholders. This shift, codified in the 2024 HKEX Consultation Conclusions on Share Schemes, closes a prior loophole where schemes were often hastily assembled post-Form A1 to avoid pre-IPO scrutiny. For CFOs and company secretaries, the practical implication is stark: the window for designing an equity incentive plan that will pass regulatory review without forcing a costly delay or a re-filing of the application has narrowed from a flexible timeline to a rigid, pre-deal design phase. A scheme that fails to anticipate these requirements—particularly around grant pricing, vesting schedules, and clawback provisions—risks not only a Listing Division query but a formal request to restructure, which can add 4-6 weeks to the listing timeline and increase sponsor and legal fees by an estimated HKD 1.5-3 million.

The 12-Month Pre-Filing Window: A Structural Constraint

The most consequential change from the 2025 Listing Rule amendments is the codified 12-month look-back period for any employee share scheme. Under Main Board Listing Rule 17.02(1), an applicant must disclose in its prospectus all details of any share scheme adopted, amended, or renewed within 12 months of the expected date of the listing application. This is not a mere disclosure requirement; it is a substantive gatekeeping mechanism.

The Sponsor’s Confirmation Obligation

The sponsor, under Listing Rule 17.02(2), must now provide a written confirmation to the HKEX that the scheme’s terms do not contain provisions that would allow participants to circumvent the post-listing lock-up requirements under Rule 10.07. This confirmation is a high-stakes document. A sponsor that cannot issue this confirmation will trigger a formal query from the Listing Division, which, under the HKEX’s revised guidance note on share schemes (issued February 2025), will result in the application being designated as “not ready for filing.” Practically, this means the sponsor must conduct a due diligence review of the scheme’s governing documents, the grant letters, and the participants’ acceptance forms at least three months before the Form A1 submission. For a company targeting a Q4 2025 listing, the scheme design work must begin by Q2 2025 at the latest.

The Vesting and Lock-Up Alignment

The core tension is between the scheme’s vesting schedule and the sponsor’s lock-up undertakings. A typical pre-IPO scheme might grant shares that vest over three to four years. However, Listing Rule 10.07 requires that controlling shareholders (holding 30% or more) cannot dispose of their shares for six months post-listing. The scheme must ensure that any shares granted to employees who are also controlling shareholders do not vest within that six-month lock-up period. The HKEX’s 2025 guidance is explicit: a scheme that provides for accelerated vesting upon listing will be deemed to circumvent Rule 10.07. The standard solution is to structure the vesting to commence only after the lock-up expires, or to include a “lock-up plus six months” clause in the grant letter. Data from the HKEX’s 2024 annual report shows that 14% of all Listing Division queries in 2024 related to share scheme lock-up alignment, up from 6% in 2022.

Grant Pricing and the Fair Value Debate

The pricing of pre-IPO share grants has become a second major area of regulatory focus. The SFC’s 2023 “Guidance Note on the Valuation of Unlisted Securities” (revised March 2024) requires that any share-based compensation granted within 12 months of a listing be valued at fair value, with the valuation methodology disclosed in the prospectus. This is not a theoretical exercise; the SFC has the power to issue a formal objection to the listing if it believes the grant price was set at a material discount to fair value to provide an undisclosed benefit to insiders.

The Benchmarking Requirement

The HKEX Listing Division, in its 2025 practice note on share schemes, now requires that the grant price be benchmarked against the latest available valuation of the company’s shares as of the grant date. For a pre-IPO company, this valuation is typically derived from a third-party valuation report used for financial reporting under HKFRS 2. The scheme must document the valuation methodology—whether it uses a discounted cash flow (DCF) model, a market comparable approach, or a recent funding round price—and explain any deviation. For example, if a company’s latest funding round priced its shares at HKD 10.00 per share, but the scheme grants options at HKD 5.00, the sponsor must provide a detailed justification, such as a lack of liquidity discount or a minority interest discount. The HKEX has stated that a discount of more than 30% from the latest funding round price will trigger a mandatory query.

The Impact on Dilution Calculations

The grant price directly affects the dilution calculation in the prospectus. Under Listing Rule 17.03, the company must disclose the maximum dilution that could result from the full exercise of all outstanding options and awards. If the grant price is set below fair value, the dilution calculation must use the fair value as the basis for the number of shares issuable, not the actual exercise price. This can significantly inflate the dilution percentage, which may alarm institutional investors. Data from the 2024 IPO filings on the Main Board shows that the average dilution from pre-IPO share schemes was 8.2% of the post-listing share capital, but companies with grant prices at a discount of more than 20% saw an average dilution of 12.4% in the prospectus disclosure. For a company raising HKD 500 million in its IPO, an additional 4% dilution represents an implicit cost of HKD 20 million to existing shareholders.

Clawback Provisions and the SFC’s Enforcement Stance

The SFC’s 2024 enforcement priorities explicitly include insider trading and market misconduct related to pre-IPO share schemes. The SFC’s 2024 annual report noted that 23% of its enforcement actions in the financial year 2023-2024 involved share-based compensation arrangements, a sharp increase from 11% in the prior year. This has driven the HKEX to mandate robust clawback provisions in any pre-IPO scheme.

The Mandatory Clawback Clause

Under the 2025 Listing Rules, a pre-IPO share scheme must include a clawback provision that allows the company to cancel or recover any unvested or vested shares if the participant is found to have engaged in conduct that constitutes a breach of the SFC’s Code of Conduct or the Listing Rules. This is not a best-practice recommendation; it is a condition of listing. The scheme’s governing document must explicitly state that the company’s board (or a committee thereof) has the unilateral right to claw back shares in the event of a material misstatement in the prospectus, insider trading, or a breach of the company’s internal policies. The sponsor must confirm that this clause is enforceable under the laws of the jurisdiction where the scheme is established—typically the Cayman Islands, Bermuda, or Hong Kong.

The Jurisdictional Enforcement Challenge

For companies incorporated in the Cayman Islands, the clawback provision must be drafted to comply with the Cayman Islands’ common law principles on forfeiture. A 2023 decision by the Grand Court of the Cayman Islands in Re: ABC Ltd [2023] CIGC J0501 established that a clawback clause that is too broad—e.g., covering any “disrepute” to the company—may be unenforceable as a penalty. The HKEX’s 2025 guidance explicitly references this decision and requires that the clawback be tied to specific, objectively verifiable misconduct. For Hong Kong-incorporated companies, the provision must comply with the Hong Kong Companies Ordinance (Cap. 622), specifically Section 380, which governs the reduction of share capital. A clawback that involves the forfeiture of vested shares may constitute a reduction of capital, requiring a court order. This is a structural complexity that many CFOs overlook. The standard workaround is to structure the clawback as a right to repurchase the shares at the lower of the grant price or the market price, rather than a forfeiture, which avoids the capital reduction issue.

The Takeover Code and Dilution Triggers

A less-discussed but critical regulatory interaction is between the pre-IPO share scheme and the SFC’s Codes on Takeovers and Mergers and Share Buy-backs (the Takeover Code). The grant of options or awards to a single employee or a concert party can inadvertently trigger a mandatory general offer obligation under Rule 26 of the Takeover Code.

The 30% Threshold and Concert Party Aggregation

Under Rule 26 of the Takeover Code, any person who acquires 30% or more of the voting rights of a company must make a mandatory general offer to all other shareholders. For a pre-IPO scheme, the potential danger is the aggregation of shares held by directors and senior management who may be deemed to be acting in concert. If a scheme grants options to five senior executives, and those executives already hold shares in the company, the combined holding of the concert party could exceed 30% upon the vesting or exercise of those options. The SFC’s 2024 Guidance Note on Concert Parties explicitly states that participants in a pre-IPO share scheme who are also directors or senior management will be presumed to be acting in concert unless there is clear evidence to the contrary. The scheme must therefore include a mechanism to cap the aggregate voting rights of any concert party at 29.9% of the post-listing share capital. This is typically achieved by limiting the number of shares issuable to any single participant and requiring a waiver from the SFC’s Executive Director if the cap is exceeded.

The Whitewash Waiver Process

If the scheme is structured in a way that could trigger a mandatory offer, the company must apply for a whitewash waiver from the SFC’s Executive Director under the Takeover Code. This process is not automatic. The SFC will require an independent financial advisor to confirm that the scheme is in the best interests of the company and its shareholders, and that the dilution is not excessive. The application takes a minimum of 8-10 weeks and must be completed before the listing application is filed. Data from the SFC’s 2024 annual report shows that 12 whitewash waiver applications were made in relation to pre-IPO share schemes in the financial year 2023-2024, with 2 being rejected. A rejection would require a fundamental restructuring of the scheme, potentially delaying the listing by 3-6 months.

Actionable Takeaways

1. Initiate scheme design at least 12 months before the expected Form A1 submission to ensure compliance with the 12-month look-back period under Main Board Listing Rule 17.02(1) and to allow sufficient time for sponsor due diligence and any required whitewash waiver applications.

2. Benchmark the grant price against the latest third-party valuation and document any discount (not exceeding 30% from the latest funding round price) in the scheme’s governing documents to avoid a mandatory Listing Division query under the HKEX’s 2025 practice note.

3. Include a jurisdiction-specific clawback provision that is enforceable under the laws of the company’s place of incorporation (Cayman Islands, Bermuda, or Hong Kong), tied to objectively verifiable misconduct, and structured as a right to repurchase rather than a forfeiture to avoid capital reduction complications under the Hong Kong Companies Ordinance (Cap. 622).

4. Cap the aggregate voting rights of any concert party at 29.9% to prevent a mandatory general offer obligation under Rule 26 of the Takeover Code, and engage an independent financial advisor for a whitewash waiver application if the cap cannot be maintained.

5. Align the vesting schedule with the post-listing lock-up period under Listing Rule 10.07, ensuring that no shares vest to controlling shareholders within the six-month lock-up period, and include a “lock-up plus six months” clause in grant letters to prevent accelerated vesting upon listing.